Skip to Content

Flublok Approval History

  • FDA approved: Yes (First approved January 16th, 2013)
  • Brand name: Flublok
  • Generic name: influenza vaccine
  • Company: Protein Sciences Corp.
  • Treatment for: Influenza Prophylaxis

Flublok (influenza vaccine, recombinant hemagglutinin) is an influenza vaccine indicated for active immunization against seasonal influenza in adults 18 years of age and older .

Flublok is manufactured using modern cell culture technology, and does not contain any preservatives (e.g., thimerosal, which contains mercury), egg proteins, gelatin or latex.

Flublok is administered via intramuscular (IM) injection annually prior to flu season. The most commonly reported side effect is pain at the injection site. Headache, fatigue or muscle aches may also occur.

Development History and FDA Approval Process for Flublok

Oct 11, 2016Approval FDA Approves Flublok Quadrivalent Influenza Vaccine
Jun 23, 2016Approval FDA Approved Longer Shelf Life for the Game Changer, Flublok Influenza Vaccine
Oct 29, 2014Approval Flublok Influenza Vaccine Now Approved for Adults Ages 18 and Older
Jan 16, 2013Approval FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.